Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Bo Sung Kim*, Jong Young Oh**, Kyung Jin Nam*, Jin Han Cho*, Hee Jin Kwon*, Seong Kuk Yoon*, Jin Sook Jeong
*Department of Radiology, Dong-A University College of Medicine, Busan, Korea.
†Department of Pathology, Dong-A University College of Medicine, Busan, Korea.
‡Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
Correspondence to: Jong Young Oh. Department of Radiology, Dong-A Medical Center, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea. Tel: +82-51-240-5367, Fax: +82-51-253-4931, ohjy@dau.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gut Liver 2014;8(2):219-223. https://doi.org/10.5009/gnl.2014.8.2.219
Published online December 24, 2013, Published date March 29, 2014
Copyright © Gut and Liver.
The objective of our study was to identify useful computed tomography (CT) findings for differentiating fundal type adenomyomatosis from localized chronic cholecystitis involving the fundus of the gallbladder.
We retrospectively identified cases of 41 patients with pathologically proven adenomyomatosis (n=21) or chronic cholecystitis (n=20) who had fundal thickening of the gallbladder on preoperative abdominal CT. Analysis of the CT findings included evaluation of the thickness, contour, border, intralesional cystic area, adjacent gallbladder wall thickening, presence of inner layer enhancement, enhancement grade, enhancement pattern, and presence of stones. Statistical analyses were performed using the Mann-Whitney U test and Fisher exact test.
Oval contour, inner layer enhancement and intralesional cystic area were more frequently noted in adenomyomatosis than in chronic cholecystitis (p<0.05 for each finding). Flat contour and adjacent gallbladder wall thickening were more frequently observed in chronic cholecystitis than in adenomyomatosis. No differences between adenomyomatosis and chronic cholecystitis in terms of the thickness, enhancement grade, enhancement pattern and presence of stones were apparent.
CT may help to differentiate fundal type adenomyomatosis from localized chronic cholecystitis involving the fundus of the gallbladder.
Keywords: Adenomyomatosis, Chronic cholecystitis, Fundal type, Computed tomography
Focal gallbladder wall thickening at the fundus portion is a relatively uncommon computed tomography (CT) finding. This finding can result from a broad spectrum of pathologic conditions, such as chronic cholecystitis, gallbladder cancer, and adenomyomatosis. Among these conditions, fundal type adenomyomatosis and localized chronic cholecystitis involving fundus of the gallbladder are often indistinguishable from each other.1-3
Adenomyomatosis and chronic cholecystitis are benign diseases, so clinical significance of both diseases is not that great compare with gallbladder cancer. But they are common disease involving gallbladder and sometimes hard to distinguish. Therefore radiologic differentiation of adenomyomatosis and chronic cholecystitis might be academically meaningful and interesting.
Efforts to differentiate wall thickening of the gallbladder have been vigorously made in research using various imaging modalities including sonography, CT, and magnetic resonance imaging.2-5 Although sonography has been the screening method of choice in the diagnosis of gallbladder disease,6 making an accurate diagnosis may be difficult because thickening of the gallbladder wall is nonspecific.7,8 Furthermore, the fundus of the gallbladder may be insufficiently visualized with sonography, owing to intestinal gas and the most anterior part of gallbladder.9 Recently, multidetector CT (MDCT) has become the imaging technique that is more widely used to detect and to characterize gallbladder wall thickening. Although there was a report related to enhancement pattern of diffuse gallbladder wall thickening on MDCT,4 to our knowledge, no previously published investigation has focused on the differential diagnosis between fundal type adenomyomatosis and localized chronic cholecystitis involving fundus of the gallbladder by means of MDCT.
The purpose of this study was to evaluate the CT findings of fundal type adenomyomatosis and localized chronic cholecystitis involving the fundus of the gallbladder and to identify the useful CT findings for differentiating the two diseases.
This retrospective study was approved by our Institutional Review Board and the requirement for informed consent was waived. We searched the radiology database of our hospital for cases of focal fundal thickening of the gallbladder during the period from January 2007 to June 2011. We determined 189 patients as having focal thickening of the gallbladder fundus in our data. Of these 189 patients, 95 patients had a histopathologically confirmed diagnosis by cholecystectomy. We excluded 54 patients from the analysis for one of the following reasons: a segmental or diffuse wall thickening of the gallbladder (n=38); pathologically confirmed with gallbladder cancer (n=6); none of the CT images was available (n=10). Finally, the remaining 41 patients were enrolled in our study-that is, 21 patients with fundal type adenomyomatosis (mean age, 56.3±10.4 years; age range, 36 to 76 years old; male:female ratio, 15:6) and 20 patients with localized chronic cholecystitis (mean age, 56.3±10.4 years; age range, 36 to 76 years old; male:female ratio, 14:6). In two of the 21 patients with adenomyomatosis and three of the 20 patients with chronic cholecystitis, incidental cholecystectomy was performed at the time of abdominal surgery for other reasons such as gastric and colon cancer. The mean interval between CT and cholecystectomy was 28.8 days (range, 5 to 60 days) for adenomyomatosis and 32.0 days (range, 12 to 104 days) for chronic cholecystitis.
Contrast-enhanced CT examinations of all individuals were performed with a 16-detector row CT scanner (Somatom Sensation 16; Siemens Medical Solutions, Erlangen, Germany). Intravenous nonionic contrast material (Iopromide, Ultravist370; Schering, Berlin, Germany) was administered via the antecubital vein at a flow rate of 2 to 3 mL/sec, with an automatic power injector. CT scans were obtained routinely during full inspiration with the patient in a supine position. Single-breath hold scans were obtained from the dome of the diaphragm to the symphysis pubis in the late arterial phase (40 seconds after injection) and in the portal venous phase (70 seconds after injection). Scanning was performed with the following parameters; 120 kVp; 165 eff mAs; 16×0.75 mm2 collimation; table speed 24 mm/sec; matrix size, 512×512. Axial and coronal images were reconstructed with 5.0 mm intervals.
On a retrospective basis, two abdominal radiologists (J.Y.O. and H.J.K., with 15 and 9 years of abdominal CT experience, respectively) reviewed the CT findings in consensus. Reviewers had no knowledge of the final radiologic or pathologic findings. The images were presented to the readers in a random sequence. All CT scans were reviewed on a PACS workstation (M-view™; Marotech, Seoul, Korea).
The following parameters were reviewed in each CT: thickness of involved gallbladder wall; lesion contour; border; intralesional cystic area; adjacent gallbladder wall thickening; presence of inner layer enhancement during the portal venous phase; enhancement grade; enhancement pattern; and presence of stones. The thickness of the gallbladder wall was measured at its most thickened portion. Lesion contours were classified as oval or flat (Fig. 1A and B). In addition, lesion borders were classified as well-defined versus ill-defined. Intralesional cystic area was defined as small cystic structures within the thickened gallbladder wall. The radiologists assessed the presence of adjacent gallbladder thickening (Fig. 1C) and inner layer enhancement of each lesion (Fig. 1D). The relative enhancement grade (high, iso, or low) of the lesion was compared with the attenuation of liver parenchyma during the portal venous phase. The enhancement pattern (homogeneous/heterogeneous) and the presence of stones were analyzed, as well.
Statistical differences in the CT features of adenomyomatosis and localized chronic cholecystitis were analyzed using the Mann-Whitney U test and the Fisher exact test. The Mann-Whitney U test was used for comparing of the mean thickness of the lesion between the two groups and the Fisher exact test for other variables. Findings with a p-value of less than 0.05 were considered statistically significant. Statistical analysis was performed using a statistical software system (SPSS version 19.0 for Windows; IBM Co., Armonk, NY, USA).
The comparison of the CT findings between fundal type adenomyomatosis and localized chronic cholecystitis is shown in Table 1. Mean wall thickness in the adenomyomatosis and chronic cholecystitis groups were 9.7 and 9.4 mm. This finding was not statistically significant.
The presence of an oval contour was more frequent in patients with adenomyomatosis than in patients with chronic cholecystitis (p=0.025) (Fig. 2). However, a flat contour lesion was more commonly seen in patients with chronic cholecystitis than in those with adenomyomatosis (Fig. 3). More frequently, adenomyomatosis showed well-defined borders than chronic cholecystitis (p=0.005). An intralesional cystic area was more frequently demonstrated in adenomyomatosis than in chronic cholecystitis (p=0.006) (Fig. 4). Adjacent gallbladder wall thickening was more common in chronic cholecystitis than in adenomyomatosis (p=0.000) (Fig. 5). Inner layer enhancement of the lesion was more frequently detected in adenomyomatosis than in chronic cholecystitis (p=0.000) (Fig. 6). The enhancement grade and pattern were statistically not significant in both of them. There was no difference in the incidence of gallstone between the adenomyomatosis and chronic cholecystitis group.
Chronic cholecystitis is the most common form of clinically symptomatic gallbladder disease. Signs and symptoms are vague and include epigastric discomfort and nausea.10 The gallbladder appears small and contracted, with irregular and thickened walls. The thickened wall consists histologically of fibrosis and inflammatory cell infiltration in the subserosa and hypertrophy of the muscularis propria.11 CT imaging usually demonstrates diffuse thickening of the gallbladder wall. However, sometimes thickening is localized to the fundal portion of gallbladder wall.
Adenomyomatosis of the gallbladder is a common, distinct, noninflammatory, benign condition that has been reported in up to 2% to 8.7% of cholecystectomy specimens.1,3,9,12 Adenomyomatosis is characterized by excessive proliferation of surface epithelium with deep and branching invaginations (Rokitansky-Aschoff sinuses) into the thickened muscularis propria.13 Gallbladder wall thickening and intramural diverticula containing bile, cholesterol crystals, sludge, or calculi are well correlated with distinctive multimodality imaging features of adenomyomatosis.14
Adenomyomatosis of the gallbladder can be classified into three types: generalized, segmental, and localized fundal.1 Diffuse or generalized adenomyomatosis consists of widespread gallbladder involvement. Segmental adenomyomatosis appears as limited circumferential gallbladder wall involvement with luminal narrowing, typically within the gallbladder body, which may produce a characteristic hourglass configuration. Focal or localized adenomyomatosis is most common, manifesting as crescentric to rounded gallbladder wall thickening, usually at the fundus.
Several previous investigators reported the CT findings for differentiating gallbladder cancer from chronic cholecystitis or adenomyomatosis. They indicated a thickened gallbladder wall with disruption or obliteration of the normal layered pattern of the wall suggests cancer.4 But, any previous reports have not focused on the differential diagnosis between fundal type adenomyomatosis and localized chronic cholecystitis.
So, in this study, we evaluated the CT findings of focal wall thickening involving the fundus of gallbladder to differentiate fundal type adenomyomatosis from localized chronic cholecystitis.
The contour and border of the lesions showed significant differences between adenomyomatosis and chronic cholecystitis (p<0.05). Adenomyomatosis showed a tendency to have well defined oval contour, whereas chronic cholecystitis revealed ill defined flat contour. This finding was well correlated with pathologic findings. In case of adenomyomatosis, the invaginated hypertrophic glands in the mucularis of the gallbladder wall were well correlated with CT features.
Adjacent gallbladder wall thickening was statistically significant in differentiating chronic cholecystitis (16/20, 80%) from adenomyomatosis (4/21, 19%). This finding may reflect that there was inflammatory extension to adjacent the gallbladder wall in chronic cholecystitis.
Kim et al.4 analyzed enhancement pattern of flat gallbladder wall thickening on MDCT. According to their results, inner layer enhancement was demonstrated in all cases of adenomyomatosis, but chronic cholecystitis showed one layer pattern without inner layer enhancement in four of 20 cases. In our study, we found similar results; inner layer enhancement was noted more commonly in adenomyomatosis (20/21, 95%) than in localized chronic cholecystitis (6/20, 30%). Therefore, identification of inner layer enhancement of thickened gallbladder wall may be helpful in differentiating adenomyomatosis from chronic cholecystitis.
Rokitansky-Aschoff sinus was defined as a small cystic structure that demonstrated water density within the thickened gallbladder wall. Identification of Rokitansky-Aschoff sinus on CT is highly specific in diagnosing adenomyomatosis.2,3,9 The detection rates of Rokitansky-Aschoff sinus on CT reported in previous studies were 36% and 38%.2,12 Similarly, the results of our study showed that intralesional cystic area was visualized in 42.9% of patients with adenomyomatosis on CT.
This study has several limitations. First, the number of patients who were enrolled in this study was small. Second, because this study was based on retrospective data, the precise correlation of the CT features with the histopathology findings was not possible. Third, because our patient population was a subset of all the patients at our institution who underwent surgery for gallbladder wall thickening, the possibility of selection bias must be considered.
In conclusion, when it comes to CT differential diagnosis of focal thickening at the fundus of gallbladder, oval contour, presence of inner layer enhancement, and intralesional cystic area are more frequently seen in fundal type adenomyomatosis than in localized chronic cholecystitis. Conversely, flat contour and adjacent gallbladder wall thickening are more favorable findings in chronic cholecystitis rather than in adenomyomatosis.
Data are presented as mean±SD or number (%).
*Mann-Whitney U test; †Fisher exact test.
*Mann-Whitney U test; †Fisher exact test.
Gut Liver 2014; 8(2): 219-223
Published online March 29, 2014 https://doi.org/10.5009/gnl.2014.8.2.219
Copyright © Gut and Liver.
Bo Sung Kim*, Jong Young Oh**, Kyung Jin Nam*, Jin Han Cho*, Hee Jin Kwon*, Seong Kuk Yoon*, Jin Sook Jeong
*Department of Radiology, Dong-A University College of Medicine, Busan, Korea.
†Department of Pathology, Dong-A University College of Medicine, Busan, Korea.
‡Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
Correspondence to: Jong Young Oh. Department of Radiology, Dong-A Medical Center, Dong-A University College of Medicine, 26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea. Tel: +82-51-240-5367, Fax: +82-51-253-4931, ohjy@dau.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The objective of our study was to identify useful computed tomography (CT) findings for differentiating fundal type adenomyomatosis from localized chronic cholecystitis involving the fundus of the gallbladder.
We retrospectively identified cases of 41 patients with pathologically proven adenomyomatosis (n=21) or chronic cholecystitis (n=20) who had fundal thickening of the gallbladder on preoperative abdominal CT. Analysis of the CT findings included evaluation of the thickness, contour, border, intralesional cystic area, adjacent gallbladder wall thickening, presence of inner layer enhancement, enhancement grade, enhancement pattern, and presence of stones. Statistical analyses were performed using the Mann-Whitney U test and Fisher exact test.
Oval contour, inner layer enhancement and intralesional cystic area were more frequently noted in adenomyomatosis than in chronic cholecystitis (p<0.05 for each finding). Flat contour and adjacent gallbladder wall thickening were more frequently observed in chronic cholecystitis than in adenomyomatosis. No differences between adenomyomatosis and chronic cholecystitis in terms of the thickness, enhancement grade, enhancement pattern and presence of stones were apparent.
CT may help to differentiate fundal type adenomyomatosis from localized chronic cholecystitis involving the fundus of the gallbladder.
Keywords: Adenomyomatosis, Chronic cholecystitis, Fundal type, Computed tomography
Focal gallbladder wall thickening at the fundus portion is a relatively uncommon computed tomography (CT) finding. This finding can result from a broad spectrum of pathologic conditions, such as chronic cholecystitis, gallbladder cancer, and adenomyomatosis. Among these conditions, fundal type adenomyomatosis and localized chronic cholecystitis involving fundus of the gallbladder are often indistinguishable from each other.1-3
Adenomyomatosis and chronic cholecystitis are benign diseases, so clinical significance of both diseases is not that great compare with gallbladder cancer. But they are common disease involving gallbladder and sometimes hard to distinguish. Therefore radiologic differentiation of adenomyomatosis and chronic cholecystitis might be academically meaningful and interesting.
Efforts to differentiate wall thickening of the gallbladder have been vigorously made in research using various imaging modalities including sonography, CT, and magnetic resonance imaging.2-5 Although sonography has been the screening method of choice in the diagnosis of gallbladder disease,6 making an accurate diagnosis may be difficult because thickening of the gallbladder wall is nonspecific.7,8 Furthermore, the fundus of the gallbladder may be insufficiently visualized with sonography, owing to intestinal gas and the most anterior part of gallbladder.9 Recently, multidetector CT (MDCT) has become the imaging technique that is more widely used to detect and to characterize gallbladder wall thickening. Although there was a report related to enhancement pattern of diffuse gallbladder wall thickening on MDCT,4 to our knowledge, no previously published investigation has focused on the differential diagnosis between fundal type adenomyomatosis and localized chronic cholecystitis involving fundus of the gallbladder by means of MDCT.
The purpose of this study was to evaluate the CT findings of fundal type adenomyomatosis and localized chronic cholecystitis involving the fundus of the gallbladder and to identify the useful CT findings for differentiating the two diseases.
This retrospective study was approved by our Institutional Review Board and the requirement for informed consent was waived. We searched the radiology database of our hospital for cases of focal fundal thickening of the gallbladder during the period from January 2007 to June 2011. We determined 189 patients as having focal thickening of the gallbladder fundus in our data. Of these 189 patients, 95 patients had a histopathologically confirmed diagnosis by cholecystectomy. We excluded 54 patients from the analysis for one of the following reasons: a segmental or diffuse wall thickening of the gallbladder (n=38); pathologically confirmed with gallbladder cancer (n=6); none of the CT images was available (n=10). Finally, the remaining 41 patients were enrolled in our study-that is, 21 patients with fundal type adenomyomatosis (mean age, 56.3±10.4 years; age range, 36 to 76 years old; male:female ratio, 15:6) and 20 patients with localized chronic cholecystitis (mean age, 56.3±10.4 years; age range, 36 to 76 years old; male:female ratio, 14:6). In two of the 21 patients with adenomyomatosis and three of the 20 patients with chronic cholecystitis, incidental cholecystectomy was performed at the time of abdominal surgery for other reasons such as gastric and colon cancer. The mean interval between CT and cholecystectomy was 28.8 days (range, 5 to 60 days) for adenomyomatosis and 32.0 days (range, 12 to 104 days) for chronic cholecystitis.
Contrast-enhanced CT examinations of all individuals were performed with a 16-detector row CT scanner (Somatom Sensation 16; Siemens Medical Solutions, Erlangen, Germany). Intravenous nonionic contrast material (Iopromide, Ultravist370; Schering, Berlin, Germany) was administered via the antecubital vein at a flow rate of 2 to 3 mL/sec, with an automatic power injector. CT scans were obtained routinely during full inspiration with the patient in a supine position. Single-breath hold scans were obtained from the dome of the diaphragm to the symphysis pubis in the late arterial phase (40 seconds after injection) and in the portal venous phase (70 seconds after injection). Scanning was performed with the following parameters; 120 kVp; 165 eff mAs; 16×0.75 mm2 collimation; table speed 24 mm/sec; matrix size, 512×512. Axial and coronal images were reconstructed with 5.0 mm intervals.
On a retrospective basis, two abdominal radiologists (J.Y.O. and H.J.K., with 15 and 9 years of abdominal CT experience, respectively) reviewed the CT findings in consensus. Reviewers had no knowledge of the final radiologic or pathologic findings. The images were presented to the readers in a random sequence. All CT scans were reviewed on a PACS workstation (M-view™; Marotech, Seoul, Korea).
The following parameters were reviewed in each CT: thickness of involved gallbladder wall; lesion contour; border; intralesional cystic area; adjacent gallbladder wall thickening; presence of inner layer enhancement during the portal venous phase; enhancement grade; enhancement pattern; and presence of stones. The thickness of the gallbladder wall was measured at its most thickened portion. Lesion contours were classified as oval or flat (Fig. 1A and B). In addition, lesion borders were classified as well-defined versus ill-defined. Intralesional cystic area was defined as small cystic structures within the thickened gallbladder wall. The radiologists assessed the presence of adjacent gallbladder thickening (Fig. 1C) and inner layer enhancement of each lesion (Fig. 1D). The relative enhancement grade (high, iso, or low) of the lesion was compared with the attenuation of liver parenchyma during the portal venous phase. The enhancement pattern (homogeneous/heterogeneous) and the presence of stones were analyzed, as well.
Statistical differences in the CT features of adenomyomatosis and localized chronic cholecystitis were analyzed using the Mann-Whitney U test and the Fisher exact test. The Mann-Whitney U test was used for comparing of the mean thickness of the lesion between the two groups and the Fisher exact test for other variables. Findings with a p-value of less than 0.05 were considered statistically significant. Statistical analysis was performed using a statistical software system (SPSS version 19.0 for Windows; IBM Co., Armonk, NY, USA).
The comparison of the CT findings between fundal type adenomyomatosis and localized chronic cholecystitis is shown in Table 1. Mean wall thickness in the adenomyomatosis and chronic cholecystitis groups were 9.7 and 9.4 mm. This finding was not statistically significant.
The presence of an oval contour was more frequent in patients with adenomyomatosis than in patients with chronic cholecystitis (p=0.025) (Fig. 2). However, a flat contour lesion was more commonly seen in patients with chronic cholecystitis than in those with adenomyomatosis (Fig. 3). More frequently, adenomyomatosis showed well-defined borders than chronic cholecystitis (p=0.005). An intralesional cystic area was more frequently demonstrated in adenomyomatosis than in chronic cholecystitis (p=0.006) (Fig. 4). Adjacent gallbladder wall thickening was more common in chronic cholecystitis than in adenomyomatosis (p=0.000) (Fig. 5). Inner layer enhancement of the lesion was more frequently detected in adenomyomatosis than in chronic cholecystitis (p=0.000) (Fig. 6). The enhancement grade and pattern were statistically not significant in both of them. There was no difference in the incidence of gallstone between the adenomyomatosis and chronic cholecystitis group.
Chronic cholecystitis is the most common form of clinically symptomatic gallbladder disease. Signs and symptoms are vague and include epigastric discomfort and nausea.10 The gallbladder appears small and contracted, with irregular and thickened walls. The thickened wall consists histologically of fibrosis and inflammatory cell infiltration in the subserosa and hypertrophy of the muscularis propria.11 CT imaging usually demonstrates diffuse thickening of the gallbladder wall. However, sometimes thickening is localized to the fundal portion of gallbladder wall.
Adenomyomatosis of the gallbladder is a common, distinct, noninflammatory, benign condition that has been reported in up to 2% to 8.7% of cholecystectomy specimens.1,3,9,12 Adenomyomatosis is characterized by excessive proliferation of surface epithelium with deep and branching invaginations (Rokitansky-Aschoff sinuses) into the thickened muscularis propria.13 Gallbladder wall thickening and intramural diverticula containing bile, cholesterol crystals, sludge, or calculi are well correlated with distinctive multimodality imaging features of adenomyomatosis.14
Adenomyomatosis of the gallbladder can be classified into three types: generalized, segmental, and localized fundal.1 Diffuse or generalized adenomyomatosis consists of widespread gallbladder involvement. Segmental adenomyomatosis appears as limited circumferential gallbladder wall involvement with luminal narrowing, typically within the gallbladder body, which may produce a characteristic hourglass configuration. Focal or localized adenomyomatosis is most common, manifesting as crescentric to rounded gallbladder wall thickening, usually at the fundus.
Several previous investigators reported the CT findings for differentiating gallbladder cancer from chronic cholecystitis or adenomyomatosis. They indicated a thickened gallbladder wall with disruption or obliteration of the normal layered pattern of the wall suggests cancer.4 But, any previous reports have not focused on the differential diagnosis between fundal type adenomyomatosis and localized chronic cholecystitis.
So, in this study, we evaluated the CT findings of focal wall thickening involving the fundus of gallbladder to differentiate fundal type adenomyomatosis from localized chronic cholecystitis.
The contour and border of the lesions showed significant differences between adenomyomatosis and chronic cholecystitis (p<0.05). Adenomyomatosis showed a tendency to have well defined oval contour, whereas chronic cholecystitis revealed ill defined flat contour. This finding was well correlated with pathologic findings. In case of adenomyomatosis, the invaginated hypertrophic glands in the mucularis of the gallbladder wall were well correlated with CT features.
Adjacent gallbladder wall thickening was statistically significant in differentiating chronic cholecystitis (16/20, 80%) from adenomyomatosis (4/21, 19%). This finding may reflect that there was inflammatory extension to adjacent the gallbladder wall in chronic cholecystitis.
Kim et al.4 analyzed enhancement pattern of flat gallbladder wall thickening on MDCT. According to their results, inner layer enhancement was demonstrated in all cases of adenomyomatosis, but chronic cholecystitis showed one layer pattern without inner layer enhancement in four of 20 cases. In our study, we found similar results; inner layer enhancement was noted more commonly in adenomyomatosis (20/21, 95%) than in localized chronic cholecystitis (6/20, 30%). Therefore, identification of inner layer enhancement of thickened gallbladder wall may be helpful in differentiating adenomyomatosis from chronic cholecystitis.
Rokitansky-Aschoff sinus was defined as a small cystic structure that demonstrated water density within the thickened gallbladder wall. Identification of Rokitansky-Aschoff sinus on CT is highly specific in diagnosing adenomyomatosis.2,3,9 The detection rates of Rokitansky-Aschoff sinus on CT reported in previous studies were 36% and 38%.2,12 Similarly, the results of our study showed that intralesional cystic area was visualized in 42.9% of patients with adenomyomatosis on CT.
This study has several limitations. First, the number of patients who were enrolled in this study was small. Second, because this study was based on retrospective data, the precise correlation of the CT features with the histopathology findings was not possible. Third, because our patient population was a subset of all the patients at our institution who underwent surgery for gallbladder wall thickening, the possibility of selection bias must be considered.
In conclusion, when it comes to CT differential diagnosis of focal thickening at the fundus of gallbladder, oval contour, presence of inner layer enhancement, and intralesional cystic area are more frequently seen in fundal type adenomyomatosis than in localized chronic cholecystitis. Conversely, flat contour and adjacent gallbladder wall thickening are more favorable findings in chronic cholecystitis rather than in adenomyomatosis.
Table 1 Computed Tomography Findings of Fundal Type Adenomyomatosis and Localized Chronic Cholecystitis
Data are presented as mean±SD or number (%).
*Mann-Whitney U test; †Fisher exact test.
*Mann-Whitney U test; †Fisher exact test.